FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Covalon Technologies Ltd. Stock AnalysisComprehensive stock analysis for Covalon Technologies Ltd. (CVALF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCVALF
CVALF
Covalon Technologies Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CVALF
Home🔹Stocks🔹Covalon Technologies Ltd.

Covalon Technologies Ltd.

🇺🇸CVALF•OTC

Covalon Technologies Ltd.

🇺🇸CVALF•OTC
Market cap
$35.92M
Sentiment

Your view on CVALF

Mkt Cap
$35.92M
Sentiment
Your view
CVALF
Covalon Technologies Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CVALF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Covalon Technologies Ltd.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Brent Ashton
Headquarters
1660 Tech Avenue, Mississauga, ON, CA
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Brent Ashton
Headquarters
1660 Tech Avenue, Mississauga, ON, CA
Description

Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally.

The company has 3 proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity; and medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device.

Its products include wound care dressings; surgical and peri-operative products; and infection management products. The company offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force.

It serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. The company is headquartered in Mississauga, Canada.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Covalon Technologies Ltd., and the rating behind it. CVALF last traded at $1.31, 21.0× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Covalon Technologies Ltd.. Starting points for Covalon Technologies Ltd.: P/E 21.0, EPS $0.16, beta -0.24 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Covalon Technologies Ltd.. Covalon Technologies Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Covalon Technologies Ltd.. Trailing twelve-month EPS for Covalon Technologies Ltd. stands at $0.16. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Covalon Technologies Ltd.. Covalon Technologies Ltd. has reported as a listed company since 2007. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Covalon Technologies Ltd. valued side by side against its closest peers. Covalon Technologies Ltd. is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Covalon Technologies Ltd., and how their positions are changing. At a $35.9M market value, institutional positions materially move Covalon Technologies Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Covalon Technologies Ltd. executives and directors. Shares of Covalon Technologies Ltd. have traded between $1.16 and $2.14 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Covalon Technologies Ltd.. Covalon Technologies Ltd. is a $35.9M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Covalon Technologies Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Covalon Technologies Ltd.. Coverage tracks Covalon Technologies Ltd. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • ACHFF — Arch Biopartners Inc.
  • CYYNF — Cynata Therapeutics Limited
  • HBPCF — Helix BioPharma Corp.
  • INNMF — Amplia Therapeutics Limited
  • MMIRF — MedMira Inc.
  • OTLC — Oncotelic Therapeutics, Inc.
  • PSYBF — PsyBio Therapeutics Corp.
  • RLFTF — Relief Therapeutics Holding AG

More Medical - Instruments & Supplies companies

  • SVSO — SheerVision, Inc.
  • TCGGY — Tecan Group AG
  • TCHBF — Tecan Group AG
  • TDVXF — Tobii Dynavox AB (publ)
  • TFX — Teleflex Incorporated
  • TGLVY — Top Glove Corporation Bhd.
  • TRJ.AX — Trajan Group Holdings Limited
  • TRUMF — Terumo Corporation
  • TRUMY — Terumo Corporation
  • TSNLF — Tristel PLC
  • TUTH — Standard Dental Labs Inc.
  • UTMD — Utah Medical Products, Inc.

News

Latest Market News